STING1 and neoplasm: The cGAS-STING pathway, central to this interaction, is a key innate immunity component that responds to cytosolic DNA, including tumor-derived DNA, triggering inflammatory responses and antitumor immunity through the production of IFN-1 and other cytokines (58–62).